Chongqing Boteng Pharmaceutical Technology Co., Ltd. evaluates the performance of the accounting firm for the year 2025 in accordance with the "Company Law of the People's Republic of China," "Securities Law of the People's Republic of China," "Guidelines for the Governance of Listed Companies," "Management Measures for the Appointment of Accounting Firms by State-owned Enterprises and Listed Companies," "Self-regulatory Supervision Guidelines No. 2 for Listed Companies on the Shenzhen Stock Exchange - Standard Operation of GEM Listed Companies," and other relevant regulations and requirements.
I. Basic Information of the 2025 Annual Audit Accounting Firm
(1) Basic Information
| Item | Details |
|---|
| Firm Name | Tianjian Accounting Firm (Special General Partnership) |
| Establishment Date | July 18, 2011 |
| Organizational Form | Special General Partnership |
| Registered Address | 128 Xixi Road, Lingyin Street, Xihu District, Hangzhou, Zhejiang Province |
| Chief Partner | Zhong Jianguo |
| Number of Partners at Year-End | 250 |
| Number of Practicing Personnel at Year-End | 2,363 |
| Number of CPAs Signing Audit Reports for Securities Services | 954 |
2024 Business Revenue
| Item | Amount (in billion yuan) |
|---|
| Total Business Revenue | 29.69 |
| Audit Business Revenue | 25.63 |
| Securities Business Revenue | 14.65 |